Cite
HARVARD Citation
Risitano, A. et al. (2021). Addition of iptacopan, an oral factor B inhibitor, to eculizumab in patients with paroxysmal nocturnal haemoglobinuria and active haemolysis: an open-label, single-arm, phase 2, proof-of-concept trial. Lancet. 8 (5), pp. e344-e354. [Online].